Treatment of severe hypertriglyceridaemia

Affiliations

¹ British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK. Electronic address: david.preiss@glasgow.ac.uk.
² British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

Comment

David Preiss et al. Lancet Diabetes Endocrinol. 2014 Nov.

. 2014 Nov;2(11):860.

doi: 10.1016/S2213-8587(14)70052-X. Epub 2014 Mar 20.

¹ British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK. Electronic address: david.preiss@glasgow.ac.uk.
² British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

No abstract available

Comment in

Treatment of severe hypertriglyceridaemia--authors' reply.
Chapman MJ, Ginsberg HN, Hegele RA. Chapman MJ, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):860-1. doi: 10.1016/S2213-8587(14)70054-3. Epub 2014 Mar 20. Lancet Diabetes Endocrinol. 2014. PMID: 25439460 No abstract available.

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.
Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Borén J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A, Watts GF, Wiklund O; European Atherosclerosis Society Consensus Panel. Hegele RA, et al. Lancet Diabetes Endocrinol. 2014 Aug;2(8):655-66. doi: 10.1016/S2213-8587(13)70191-8. Epub 2013 Dec 23. Lancet Diabetes Endocrinol. 2014. PMID: 24731657 Free PMC article. Review.